Registering a CAGR of 13.02% over the forecast period, the market value of Stem Cells is expected to reach US$ 28.2 billion in the year 2027.
Cell research has the greatest potential to transform the way complex diseases are treated. They are natural and have the ability to regenerate any cell type in the body. Furthermore, they are more interesting to the research scientist in terms of the development and discovery of novel therapies. These cells derived from cord blood have a high potential because they have the ability to divide into any cell type. The introduction of advanced therapies has heightened patient expectations. As a result, countries all over the world have made significant investments in the product's research and development.
The rising prevalence of chronic diseases has created opportunities for the R&D sector to use the product to develop novel therapies. Mesenchymal cells and iPSCs are widely used by researchers worldwide to conduct a variety of studies against oncology, Alzheimer's disease, Parkinson's disease, COVID-19, and other diseases. According to the stem cell portal, there are currently over 5,000 clinical trials registered for the product's use in regenerative medicine and drug development. The majority of clinical trials are focused on regenerative medicine. As a result, the increasing number of clinical trials is expected to drive market growth during the forecast period.
Industry Updates:
Stem Cells Market is segmented based on the type, applications, companies and regions.
Market Volume (%) By Type, it is segmented into
Market Volume (%) By Applications it is segmented into
North America had a market value of USD 5.80 billion in 2020 and is expected to dominate the global market. The dominance is due to the rising prevalence of chronic diseases among populations in need of effective treatments. Because of the benefits of using them for treatment, this has greatly accelerated R&D. For example, Blue Rock Therapeutics, a subsidiary of Bayer AG, announced in January 2021 that the US FDA had approved an investigational new drug (IND) application for the study of its product in advanced Parkinson's disease. In patients, pluripotent stem cell-derived dopaminergic neurons will be used in the study. Another factor driving growth is the introduction of several advanced products in the United States. Following North America, the European market holds the second-largest share of the market. This is primarily due to significant investments in research and development activities for the development of novel therapies and drugs. This, combined with increasing product sales, is expected to drive market growth. Due to the increasing use of cell lines for research and clinical applications, Asia Pacific is expected to have the highest compound annual growth rate (CAGR).
All these factors greatly affect the Stem Cells market growth. It further aims at providing complete overview on detailed assessment of significant features of different industries including sales value, sales volume, market revenue, and demand size, sales growth, pricing analysis and changing market growth factors in regions such as Follows,
The Stem Cells Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Stem Cells Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
The report includes in-depth assessment of the competitive landscape, product market sizing (Value and Volume), product benchmarking, market trends, product developments, financial analysis, strategic analysis and many more to measure the impact forces and potential opportunities of the market. As well as this the report also includes a study of major developments in the market like product launches, agreements, acquisitions, collaborations, mergers and many more to comprehend the prevailing market dynamics at current and its impact in the forecast period 2012-2027.
Report Attributes | Report Details |
Forecast Period 2022 to 2027 CAGR (Value and Volume) | CAGR of 13.02% during the review period (2022 to 2027). |
Market Volume (%) By Type(Revenue, USD Million, 2017 - 2022) |
|
Market Volume (%) By Type(Revenue, USD Million, 2017 - 2022) |
|
Quantitative units | Revenue in USD million/billion and CAGR from 2022 to 2027 |
By Companies | CCBC, Vcanbio, Boyalife, Beikebiotech, Thermo Fisher Scientific (Massachusetts, U.S), Merck KGaA, Cynata Therapeutics (Victoria, Australia), AMSBIO (Abingdon, United Kingdom) |
Regions Covered
|
|
Countries Covered |
|
Base Year
|
2022 |
Historical Year
|
2017 to 2021 |
Forecast Year
|
2022 to 2027 |
Customization Available
|
Yes, the report can be customized as per your needs. |
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
What is the study period of this market?
The Stem Cells Market is studied from 2017 - 2027.
What is the growth rate of Stem Cells Market?
The Stem Cells Market is growing at a CAGR of 13.02% over the next 5 years.
Who are the key players in Stem Cells Market?
CCBC, Vcanbio, Boyalife, Beikebiotech, Thermo Fisher Scientific (Massachusetts, U.S), Merck KGaA, Cynata Therapeutics (Victoria, Australia), AMSBIO (Abingdon, United Kingdom)
What region does this Stem Cells Market report covers?
North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
What are the significant types of Stem Cells Market?
Umbilical Cord Blood Stem Cell, Embryonic Stem Cell, Adult Stem Cell, Others
What are the major end-use applications of Stem Cells Market?
Diseases Therapy, Healthcare, Others
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.